Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Frontiers in Immunology|October 4, 2017
Immunologic Insights on the Membrane Proximal External Region: A Major Human Immunodeficiency Virus Type-1 Vaccine TargetLuis M Molinos-Albert, Bonaventura Clotet, Julià Blanco, et al.
Journal of Medical Virology|August 29, 2025
Antibody and B-Cell Responses to PHH-1V81 XBB.1.16-Adapted SARS-CoV-2 Booster Vaccination Are Associated With Variant NeutralizationCèlia Torres, Alfons Jiménez, Meritxell Deulofeu, et al.
Retrovirology|June 10, 2014
Anti-MPER antibodies with heterogeneous neutralization capacity are detectable in most untreated HIV-1 infected individualsLuis M Molinos-Albert, Jorge Carrillo, Marta Curriu, et al.
Nature Communications|October 10, 2023
HIV-1 treatment timing shapes the human intestinal memory B-cell repertoire to commensal bacteriaCyril Planchais, Luis M Molinos-Albert, Pierre Rosenbaum, et al.
Nature Communications|April 12, 2022
Transient viral exposure drives functionally-coordinated humoral immune responses in HIV-1 post-treatment controllersLuis M Molinos-Albert, Valérie Lorin, Valérie Monceaux, et al.
Science Advances|May 7, 2025
Structural basis for hepatitis E virus neutralization by potent human antibodiesLuis M Molinos-Albert, Eduard Baquero, Cyril Planchais, et al.
Microbes and Infection|September 19, 2024
High-resolution kinetics and cellular determinants of SARS-CoV-2 antibody response over two years after COVID-19 vaccinationRocío Rubio, Dídac Macià, Diana Barrios, et al.
Communications Medicine|June 24, 2026
First exposure to SARS-CoV-2 shapes IgG subclass switching after mRNA vaccinationCarla Martin Pérez, Sílvia Ruiz-Rius, Anna Ramírez-Morros, et al.
The Journal of Infection|March 20, 2025
Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infectionsCarla Martín Pérez, Sílvia Ruiz-Rius, Anna Ramírez-Morros, et al.
Pageof 3